Amrutanjan Healt

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE098F01031
  • NSEID: AMRUTANJAN
  • BSEID: 590006
INR
583.00
8.1 (1.41%)
BSENSE

Feb 03

BSE+NSE Vol: 11.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 11.50% vs 7.56% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 16.99% vs 13.89% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 23.86% vs 13.83% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -16.67% vs 80.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Amrutanjan Healt With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
352.79
0
352.79
Other Operating Income
0.00
0.00
0.00
Total Operating income
352.79
0
352.79
Raw Material Cost
75.13
0
75.13
Purchase of Finished goods
99.64
0
99.64
(Increase) / Decrease In Stocks
-3.94
0
-3.94
Employee Cost
48.11
0
48.11
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
42.46
0
42.46
Other Expenses
41.23
0.00
41.23
Total Expenditure (Excl Depreciation)
302.64
0
302.64
Operating Profit (PBDIT) excl Other Income
50.15
0.00
50.15
Other Income
12.84
0
12.84
Operating Profit (PBDIT)
62.99
0
62.99
Interest
0.15
0
0.15
Exceptional Items
-1.25
0
-1.25
Gross Profit (PBDT)
61.59
0
61.59
Depreciation
4.71
0
4.71
Profit Before Tax
56.87
0
56.87
Tax
15.14
0
15.14
Provisions and contingencies
0.00
0
0.00
Profit After Tax
41.72
0
41.72
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
41.72
0
41.72
Equity Capital
2.89
0
2.89
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
14.22%
0.00%
0.00
14.22%
Gross Profit Margin
17.46%
0.00%
0.00
17.46%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 352.79 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 11.50% vs 7.56% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 41.72 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 16.99% vs 13.89% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 50.15 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 23.86% vs 13.83% in Dec 2024

Nine Monthly - Interest
Interest 0.15 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -16.67% vs 80.00% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.22%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024